International Conference on Gene Therapy of Cancer

描述(由申请人提供)： 该提案将支持第十届至第十四届国际 专门讨论癌症基因治疗的会议。每年， 国际癌症基因治疗会议将聚焦前沿 该领域的技术。来自世界各地的顶尖研究人员将 介绍他们基础研究、临床前研究和临床研究的最新结果 利用基因治疗技术治疗癌症的研究。校长 将根据当前的重点和方向来选择主题 田野。会议的形式将为与会者提供 癌症基因治疗各学科的最新成果。受邀 演讲者之后将介绍所提供的摘要 描述最新的基础研究、临床前和临床数据。当前 会议主题包括载体系统和靶向、细胞因子和 免疫治疗，造血祖细胞，治疗耐药和 敏感性、肿瘤抑制、细胞凋亡、血管生成和癌基因 抑制力。演讲主题将在未来几年进行修改，以包括 有新的发展。每个主题会议将以该领域的概述开始 以及人体临床试验的现状。每个人的讨论时段 的演讲主题将成为会议议程的一部分， 从提交的摘要中添加口头和海报演示文稿。 这次会议将引起临床肿瘤学家的兴趣，分子 生物学家、细胞生物学家、肿瘤免疫学家和其他感兴趣的人 在这一领域工作的卫生专业人员和研究人员。

DESCRIPTION (Provided by applicant): The proposal will support the tenth through the fourteenth international conferences devoted exclusively to gene therapy of cancer. Each year, the International Conference on Gene Therapy of Cancer will focus on cutting edge technology in the field. Leading researchers from around the world will present the latest results of their basic research, pre-clinical and clinical studies of cancer treatment using gene therapy technology. The principal topics will be selected with regard to the current emphasis and direction of the field. The format of the meeting will be designed to provide participants with the latest results in all disciplines of cancer gene therapy. Invited speakers will be followed by the presentation of proffered abstracts describing recent basic research, pre-clinical, and clinical data. Current session topics include vector systems and targeting, cytokine and immunotherapy, hematopoietic progenitor cells, treatment resistance and sensitivity, and tumor suppression, apoptosis, angiogenesis, and oncogene inhibition. Presentation topics will be modified in future years to include new developments. Each topic session will begin with an overview of the field and the current status of human clinical trials. Discussion sessions for each of the presentation topics will be part of the conference agenda with additional oral and poster presentations from submitted abstracts. This conference will be of interest to clinical oncologists, molecular biologists, cellular biologists, tumor immunologists and other interested health professionals and researchers working in this field.